000141872 001__ 141872
000141872 005__ 20240229121827.0
000141872 0247_ $$2doi$$a10.1016/j.ijcard.2018.09.035
000141872 0247_ $$2pmid$$apmid:30217425
000141872 0247_ $$2ISSN$$a0167-5273
000141872 0247_ $$2ISSN$$a1874-1754
000141872 0247_ $$2altmetric$$aaltmetric:48483642
000141872 037__ $$aDKFZ-2018-02129
000141872 041__ $$aeng
000141872 082__ $$a610
000141872 1001_ $$aIttermann, Till$$b0
000141872 245__ $$aChanges in fat mass and fat-free-mass are associated with incident hypertension in four population-based studies from Germany.
000141872 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2019
000141872 3367_ $$2DRIVER$$aarticle
000141872 3367_ $$2DataCite$$aOutput Types/Journal article
000141872 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1582281992_27335
000141872 3367_ $$2BibTeX$$aARTICLE
000141872 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000141872 3367_ $$00$$2EndNote$$aJournal Article
000141872 520__ $$aWe estimated the association of changes in body weight, waist circumference (WC), fat mass (FM) and fat-free mass (FFM) with changes in blood pressure and incident hypertension using data from four German population-based studies.We analyzed data from 4467 participants, aged 21 to 82 years not taking antihypertensive medication and not having type 2 diabetes mellitus or a history of myocardial infarction at baseline and follow-up, from four population-based studies conducted in Germany. Body weight, WC, and blood pressure were measured at baseline and follow-up (median follow-up of the single studies 4 to 7 years). FM and FFM were calculated based on height-weight models derived from bioelectrical impedance studies. Hypertension was defined as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg. Confounder-adjusted linear and logistic regressions were used to associate changes in anthropometric markers with changes in blood pressure, incident hypertension, and incident normalization of blood pressure.In a pooled dataset including all four studies, increments in body weight, WC, FM, and FFM were statistically significantly associated with incident hypertension and changes in systolic and diastolic blood pressure over time. Decreases in body weight, FM, and FFM were significantly associated with incident normalization of blood pressure.Our data suggests that the well-established association between obesity and blood pressure levels might be more related to body composition rather than to total body weight per se. Our findings indicate that gaining or losing FFM has substantial impact on the development or reversion of hypertension.
000141872 536__ $$0G:(DE-HGF)POF3-323$$a323 - Metabolic Dysfunction as Risk Factor (POF3-323)$$cPOF3-323$$fPOF III$$x0
000141872 588__ $$aDataset connected to CrossRef, PubMed,
000141872 7001_ $$aWerner, Nicole$$b1
000141872 7001_ $$aLieb, Wolfgang$$b2
000141872 7001_ $$aMerz, Benedikt$$b3
000141872 7001_ $$aNöthlings, Ute$$b4
000141872 7001_ $$aKluttig, Alexander$$b5
000141872 7001_ $$aTiller, Daniel$$b6
000141872 7001_ $$0P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aGreiser, Karin-Halina$$b7$$udkfz
000141872 7001_ $$aVogt, Susanne$$b8
000141872 7001_ $$aThorand, Barbara$$b9
000141872 7001_ $$aPeters, Annette$$b10
000141872 7001_ $$aVölzke, Henry$$b11
000141872 7001_ $$aDörr, Marcus$$b12
000141872 7001_ $$aSchipf, Sabine$$b13
000141872 7001_ $$aMarkus, Marcello R P$$b14
000141872 773__ $$0PERI:(DE-600)1500478-8$$a10.1016/j.ijcard.2018.09.035$$gVol. 274, p. 372 - 377$$p372 - 377$$tInternational journal of cardiology$$v274$$x0167-5273$$y2019
000141872 909CO $$ooai:inrepo02.dkfz.de:141872$$pVDB
000141872 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000141872 9131_ $$0G:(DE-HGF)POF3-323$$1G:(DE-HGF)POF3-320$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lHerz-Kreislauf-Stoffwechselerkrankungen$$vMetabolic Dysfunction as Risk Factor$$x0
000141872 9141_ $$y2019
000141872 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000141872 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000141872 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000141872 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CARDIOL : 2017
000141872 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000141872 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000141872 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000141872 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000141872 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000141872 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000141872 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000141872 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000141872 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000141872 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000141872 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000141872 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000141872 980__ $$ajournal
000141872 980__ $$aVDB
000141872 980__ $$aI:(DE-He78)C020-20160331
000141872 980__ $$aUNRESTRICTED